Research Article
Usefulness of Measuring Thiopurine Metabolites in Children with Inflammatory Bowel Disease and Autoimmunological Hepatitis, Treated with Azathioprine
Table 1
Background information about the group receiving azathioprine.
| Characteristics | Values |
| Total number of patients | 61 | Females (percent) | 27 (44%) | Age () | | Crohn’s disease (CD) | 31 (50%) | Ulcerative colitis (UC) | 16 (26%) | Autoimmune hepatitis (AIH) | 14 (23%) | Weight SDS () | | CD | | UC | | AIH | | Height SDS () | | CD | | UC | | AIH | | BMI SDS () | | CD | | UC | | AIH | | Premonitoring azathioprine dose mg/kg () | | CD | | UC | | AIH | | Postmonitoring azathioprine dose mg/kg () | | CD | | UC | | AIH | | 6-TGN () | | CD | | UC | | AIH | | 6-MMP () | | CD | | UC | | AIH | | Disease activity: | | Remission/mild form of IBD | 32 (68%) | Moderate form of IBD | 10 (21%) | Severe form of IBD | 5 (11%) | Remission of AIH | 14 (100%) |
|
|
SD: standard deviation; 6-MMP: 6-methylmercaptopurine; 6-TGN: 6-thioguanine; IBD: inflammatory bowel disease; AIH: autoimmunological hepatitis; CD: Crohn’s disease; UC: ulcerative colitis.
|